Anxu Biotech (688075.SH) announced results for the first three quarters, with a net loss of 30.43 million yuan

Zhitongcaijing · 4d ago

According to Zhitong Finance App News, An Xu Biotech (688075.SH) disclosed its 2026 third quarter report. The company achieved revenue of 293 million yuan in the first three quarters, a year-on-year decrease of 9.94%; net profit loss to mother of 30.43 million yuan; loss of 86.15 million yuan after deducting non-net profit; and basic earnings per share - 0.27 yuan.